Cannabidiol (CBD) is one of at least 85 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract. CBD is considered to have a wider scope of medical applications than tetrahydrocannabinol (THC). An orally-administered liquid containing CBD has received orphan drug status in the US, for use as a treatment for Dravet syndrome, under the brand name Epidiolex.
- 100% natural and legal in the EU
- Patented and properly registered formulations
- Each lot tested THC below detection limit
Boris Baňas is a successful trader with hemp foods and a leading expert on industrial hemp processing and use in Slovakia. He became a member of the board of the European Industrial Hemp Association (EIHA) at the beginning of June. We asked him what his appointment to the position of this prominent institution might bring to the sector.